Gadoxetate disodium inj
Products billed under this code include Eovist, Gadoxetate Disodium.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Eovist, Gadoxetate Disodium.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Eovist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0320-15 | 75 | $1,085.25 |
| Gadoxetate Disodium | Bayer HealthCare Pharmaceuticals Inc. | 50419-0320-05 | 50 | $723.50 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $14.47 | −$0.282 | 1 ML | Gadoxetate disodium inj | v1, posted September 17, 2026 |
| 3Q26 | $14.752 | +$0.025 | 1 ML | Gadoxetate disodium inj | v1, posted September 15, 2026 |
| 2Q26 | $14.727 | −$0.026 | 1 ML | Gadoxetate disodium inj | v1, posted September 15, 2026 |
| 1Q26 | $14.753 | +$0.023 | 1 ML | Gadoxetate disodium inj | v1, posted September 15, 2026 |
| 4Q25 | $14.73 | +$0.027 | 1 ML | Gadoxetate disodium inj | v1, posted September 8, 2026 |
| 3Q25 | $14.703 | −$0.009 | 1 ML | Gadoxetate disodium inj | v1, posted March 10, 2026 |
| 2Q25 | $14.712 | +$0.011 | 1 ML | Gadoxetate disodium inj | v1, posted March 10, 2026 |
| 1Q25 | $14.701 | −$0.032 | 1 ML | Gadoxetate disodium inj | v1, posted December 19, 2025 |
| 4Q24 | $14.733 | +$0.004 | 1 ML | Gadoxetate disodium inj | v1, posted June 11, 2025 |
| 3Q24 | $14.729 | −$0.035 | 1 ML | Gadoxetate disodium inj | v1, posted June 11, 2025 |
| 2Q24 | $14.764 | +$0.023 | 1 ML | Gadoxetate disodium inj | v1, posted March 11, 2025 |
| 1Q24 | $14.741 | −$0.009 | 1 ML | Gadoxetate disodium inj | v1, posted December 19, 2024 |
| 4Q23 | $14.75 | +$0.02 | 1 ML | Gadoxetate disodium inj | v1, posted October 10, 2024 |
| 3Q23 | $14.73 | +$0.018 | 1 ML | Gadoxetate disodium inj | v1, posted June 5, 2024 |
| 2Q23 | $14.712 | −$0.036 | 1 ML | Gadoxetate disodium inj | v1, posted February 23, 2024 |
| 1Q23 | $14.748 | −$0.027 | 1 ML | Gadoxetate disodium inj | v1, posted December 6, 2023 |
| 4Q22 | $14.775 | +$0.036 | 1 ML | Gadoxetate disodium inj | v1, posted June 22, 2023 |
| 3Q22 | $14.739 | +$0.004 | 1 ML | Gadoxetate disodium inj | v1, posted June 9, 2023 |
| 2Q22 | $14.735 | −$0.003 | 1 ML | Gadoxetate disodium inj | v1, posted December 14, 2022 |
| 1Q22 | $14.738 | +$0.011 | 1 ML | Gadoxetate disodium inj | v1, posted June 8, 2022 |
| 4Q21 | $14.727 | +$0.027 | 1 ML | Gadoxetate disodium inj | v1, posted June 2, 2022 |
| 3Q21 | $14.70 | −$0.038 | 1 ML | Gadoxetate disodium inj | v1, posted June 2, 2022 |
| 2Q21 | $14.738 | +$0.003 | 1 ML | Gadoxetate disodium inj | v1, posted March 1, 2022 |
| 1Q21 | $14.735 | – | 1 ML | Gadoxetate disodium inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.